Copy from other thread:
by all means crunch the numbers about ksx going forward in next 12 months .... but factor this in also. their technology is world class and the product of ten years of research and development.
resmed is cashed up and will be very keen to get the next generation of asthma products into its portfolio.
do not by any means discount the takeover premium this stock could attract. its way higher than .10
management at ksx are very wily have shown a propensity in the past to book a profit when it comes along. all imo dyor etc etc
Copy from other thread:by all means crunch the numbers about ksx...
Add to My Watchlist
What is My Watchlist?